Literature DB >> 11681147

Gastrointestinal worm infections. The prevalence and treatment in Australia.

P Prociv1.   

Abstract

BACKGROUND: Intestinal worm (helminth) infections occur in a large proportion of the world's population, often constituting public health problems, and are occasionally encountered by practitioners in urban Australia. Prevalence levels in some remote Australian Aboriginal communities compare with those in developing countries.
OBJECTIVE: To provide general practitioners with a brief outline of the most common human intestinal helminthiases, their usual clinical presentations and how they are diagnosed and managed. DISCUSSION: The pinworm, Enteroblus vermicularis, occurs in all populations, and is the most common species of nematode encountered in suburbia. Eradication is impossible, but its numbers can be kept low in those children who seem predisposed to heavy, symptomatic infections. The other nematodes are prevalent in some remote Australian Aboriginal communities, and are encountered occasionally in travellers from overseas. These infections are often asymptomatic, they cannot spread directly to other people and so do not pose any public health threat to the general community under suburban living conditions. The tapeworms are encountered even less frequently, except for Hymenolepis, the dwarf tapeworm, which is prevalent in some Aboriginal communities.

Entities:  

Mesh:

Year:  2001        PMID: 11681147

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

1.  "Pinworm" infection of the liver: unusual CT appearance leading to hepatic resection.

Authors:  Wa Sang Watson Ng; James Gallagher; Geoffrey McCaughan
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 2.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.